Cargando…
PB1763: A PHASE 1/2 STUDY TO EVALUATE PONATINIB WITH CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH RELAPSED/RESISTANT/INTOLERANT PHILADELPHIA CHROMOSOME–POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA OR WITH T315I MUTATION
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431202/ http://dx.doi.org/10.1097/01.HS9.0000849908.11106.d2 |
| _version_ | 1784779987743670272 |
|---|---|
| author | Gore, L. Loh, M. Pui, C.-H. Matloub, Y. Hanley, M. J. Du, J. Hennessy, M. Granier, M. Biondi, A. Silverman, L. |
| author_facet | Gore, L. Loh, M. Pui, C.-H. Matloub, Y. Hanley, M. J. Du, J. Hennessy, M. Granier, M. Biondi, A. Silverman, L. |
| author_sort | Gore, L. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431202 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94312022022-08-31 PB1763: A PHASE 1/2 STUDY TO EVALUATE PONATINIB WITH CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH RELAPSED/RESISTANT/INTOLERANT PHILADELPHIA CHROMOSOME–POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA OR WITH T315I MUTATION Gore, L. Loh, M. Pui, C.-H. Matloub, Y. Hanley, M. J. Du, J. Hennessy, M. Granier, M. Biondi, A. Silverman, L. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431202/ http://dx.doi.org/10.1097/01.HS9.0000849908.11106.d2 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Gore, L. Loh, M. Pui, C.-H. Matloub, Y. Hanley, M. J. Du, J. Hennessy, M. Granier, M. Biondi, A. Silverman, L. PB1763: A PHASE 1/2 STUDY TO EVALUATE PONATINIB WITH CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH RELAPSED/RESISTANT/INTOLERANT PHILADELPHIA CHROMOSOME–POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA OR WITH T315I MUTATION |
| title | PB1763: A PHASE 1/2 STUDY TO EVALUATE PONATINIB WITH CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH RELAPSED/RESISTANT/INTOLERANT PHILADELPHIA CHROMOSOME–POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA OR WITH T315I MUTATION |
| title_full | PB1763: A PHASE 1/2 STUDY TO EVALUATE PONATINIB WITH CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH RELAPSED/RESISTANT/INTOLERANT PHILADELPHIA CHROMOSOME–POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA OR WITH T315I MUTATION |
| title_fullStr | PB1763: A PHASE 1/2 STUDY TO EVALUATE PONATINIB WITH CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH RELAPSED/RESISTANT/INTOLERANT PHILADELPHIA CHROMOSOME–POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA OR WITH T315I MUTATION |
| title_full_unstemmed | PB1763: A PHASE 1/2 STUDY TO EVALUATE PONATINIB WITH CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH RELAPSED/RESISTANT/INTOLERANT PHILADELPHIA CHROMOSOME–POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA OR WITH T315I MUTATION |
| title_short | PB1763: A PHASE 1/2 STUDY TO EVALUATE PONATINIB WITH CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH RELAPSED/RESISTANT/INTOLERANT PHILADELPHIA CHROMOSOME–POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA OR WITH T315I MUTATION |
| title_sort | pb1763: a phase 1/2 study to evaluate ponatinib with chemotherapy in pediatric patients with relapsed/resistant/intolerant philadelphia chromosome–positive acute lymphoblastic leukemia or with t315i mutation |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431202/ http://dx.doi.org/10.1097/01.HS9.0000849908.11106.d2 |
| work_keys_str_mv | AT gorel pb1763aphase12studytoevaluateponatinibwithchemotherapyinpediatricpatientswithrelapsedresistantintolerantphiladelphiachromosomepositiveacutelymphoblasticleukemiaorwitht315imutation AT lohm pb1763aphase12studytoevaluateponatinibwithchemotherapyinpediatricpatientswithrelapsedresistantintolerantphiladelphiachromosomepositiveacutelymphoblasticleukemiaorwitht315imutation AT puich pb1763aphase12studytoevaluateponatinibwithchemotherapyinpediatricpatientswithrelapsedresistantintolerantphiladelphiachromosomepositiveacutelymphoblasticleukemiaorwitht315imutation AT matlouby pb1763aphase12studytoevaluateponatinibwithchemotherapyinpediatricpatientswithrelapsedresistantintolerantphiladelphiachromosomepositiveacutelymphoblasticleukemiaorwitht315imutation AT hanleymj pb1763aphase12studytoevaluateponatinibwithchemotherapyinpediatricpatientswithrelapsedresistantintolerantphiladelphiachromosomepositiveacutelymphoblasticleukemiaorwitht315imutation AT duj pb1763aphase12studytoevaluateponatinibwithchemotherapyinpediatricpatientswithrelapsedresistantintolerantphiladelphiachromosomepositiveacutelymphoblasticleukemiaorwitht315imutation AT hennessym pb1763aphase12studytoevaluateponatinibwithchemotherapyinpediatricpatientswithrelapsedresistantintolerantphiladelphiachromosomepositiveacutelymphoblasticleukemiaorwitht315imutation AT granierm pb1763aphase12studytoevaluateponatinibwithchemotherapyinpediatricpatientswithrelapsedresistantintolerantphiladelphiachromosomepositiveacutelymphoblasticleukemiaorwitht315imutation AT biondia pb1763aphase12studytoevaluateponatinibwithchemotherapyinpediatricpatientswithrelapsedresistantintolerantphiladelphiachromosomepositiveacutelymphoblasticleukemiaorwitht315imutation AT silvermanl pb1763aphase12studytoevaluateponatinibwithchemotherapyinpediatricpatientswithrelapsedresistantintolerantphiladelphiachromosomepositiveacutelymphoblasticleukemiaorwitht315imutation |